• Metavention Initiates Trial for Novel Treatment of Type 2 Diabetes americanpharmaceuticalreview
    February 20, 2021
    Metavention announced the initiation of an U.S. Food and Drug Administration (FDA) approved clinical investigation, DeLIVER, for the Company's intravascular iRF Denervation System to determine safety in patients with type 2 diabetes (T2D).
  • Drones set to deliver drugs to remote parts of India by 2020 europeanpharmaceuticalreview
    September 23, 2019
    The government of an Indian province and a US company have teamed together in an initiative to deliver medications to remote regions using drones, which should begin next year.
PharmaSources Customer Service